Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06576934 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Early TIPS in Patients With Liver Cirrhosis and Ascites

Study acronym: eTIPS
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv5
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Collaborators: 9 to 10
    v4
  3. Start date: Feb 1, 2025 to Apr 1, 2025
    • Eligibility criteria expanded, about 1 word
    v3
  4. Start date: Oct 1, 2024 to Feb 1, 2025v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this clinical trial is to compare the safety and efficacy of transjugular intrahepatic portosystemic shunt (TIPS) implantation with standard treatment (diuretic medications, and if necessary, paracenteses) in patients with liver cirrhosis and development of ascites as the first decompensating event. By creating a shunt between the liver vein and the portal vein, blood is diverted from the portal vein directly into the hepatic vein, which results in a reduction of pressure in the portal vein so that development of ascites is reduced.
Trial Details
NCT Number NCT06576934
Lead Sponsor University Hospital Freiburg
Collaborators: Jena University Hospital, Johannes Gutenberg University Mainz, University Hospital Muenster, University Hospital, Bonn, University Hospital Munich, Hannover Medical School, University of Leipzig, University Hospital, Aachen, University Hospital Lübeck, Heinrich-Heine University, Duesseldorf
Conditions
(from sponsor)		 Liver Cirrhosis, Ascites Hepatic, Portal Hypertension
Related terms Ascites, Hypertension, Portal, Liver Cirrhosis
Enrollment 134 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov